Abstract
Some of the earliest evidence suggesting a behavioral role for peptides came from studies of pituitary-adrenal function. For example, De Wied and others demonstrated that the behavioral effects produced by removal of the pituitary could be reversed by adrenocorticotropin hormone (ACTH) and other peptides, such as vasopressin (AVP) (De Wied, 1980). Later work established that these peptides could produce profound effects on extinction of learned responses in normal animals even with synthetic analogs reputedly devoid of endocrinological activity. Variously interpreted as actions on attention (ACTH) or on memory consolidation (AVP), these effects were hypothesized to be mediated via some neural substrate. Where this substrate is located and how these pituitary-derived peptides normally interact with it remain largely unknown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ader, R., and De Wied, D., 1972, Effects of lysine vasopressin on passive avoidance learning, Psychon. Sci. 29: 46–48.
Anderson, D. C., Winard, W., and Tam, T., 1968, Adrenocorticotrophic hormone and acquisition of a passive avoidance response, J. Comp. Physiol. Psychol. 66: 497–499.
Anderson, L. T., David, R., Bonnet, K., and Dancis, J., 1979, Passive avoidance learning in Lesch-Nyhan disease: Effect of l-Desamino-8-Arginine-vasopressin, Life Sci. 24: 905–910.
Applezweig, M. H., and Baudry, F. D., 1955, The pituitary-adrenocortical system in avoidance learning, Psychol. Rep. 1: 417–420.
Asin, K. E., 1980, Lysine vasopressin attenuation of diethylidithiocarbamate-induced amnesia, Pharmacol. Biochem. Behav. 12: 343–46.
Bailey, W. H., and Weiss, J. M., 1979, Evaluation of a ‘memory deficit’ in vasopressin- deficient rats, Brain Res. 162: 174–178.
Bankowski, K., Manning, M., Haldar, J., and Sawyer, W. H., 1978, Design of potent antagonists of the vasopressor response to arginine-vasopressin, J. Med. Chem. 21: 850–53.
Baranowska, D., Braszko, J. J., and Wisnienski, K., 1983, Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats, Psychopharmacology 81: 247–251.
Bartus, R. T., Dean, R. G., and Beer, B., 1982, Neuropeptide effects on memory in aged monkeys, Neurobiol. Aging 3: 61–68.
Bayon, A., Shoemaker, W. J., McGinty, J. F., and Bloom, F., 1983, Immunodetection of endorphins and enkephalins: A search for reliability, Int. Rev. Neurobiol. 24: 51–92.
Beckwith, B. E., Petros, T., Kanaan-Beckwith, S., Couk, D. I., and Hauge, R. J., 1982, Vasopressin analog (DDAVP) facilitates concept learning in human males, Peptides 3: 627–630.
Blake, D. R., Dodd, M. J., and Evans, J. G., 1978, Vasopressin in amnesia, Lancet 1: 608.
Bohus, B., 1977, Effect of desglycinamide-lysine vasopressin (DG-LVP) on sexually motivated T-maze behavior of the male rat, Hormones Behav. 8: 52–61.
Bohus, B., and De Wied, D., 1967, Failure of α-MSH to delay extinction of conditioned avoidance behavior in rats with lesions in the parafascicular nuclei of the thalamus, Physiol. Behav. 2: 221–223.
Bohus, B., and Lissak, K., 1968, Adrenocortical hormones and avoidance behavior in rats, Int. J. Neuropharmacol. 7: 301–306.
Bohus, B., Nyakas, C. S., and Endroczi, E., 1968, Effects of adrenocorticotrophic hormone on avoidance behavior of intact and adrenalectomized rats, Int. J. Neuropharmacol. 7: 307–314.
Bohus, B., Gispen, W. H., and De Wied, D., 1973, Effect of lysine vasopressin and ACTH4–10 on conditioned avoidance behavior of hypophysectomized rats, Neuroendocrinology 11: 137–143.
Bohus, B., Hendrix, H. H. L., van Kolfschoten, A. A., and Krediet, T. G., 1975a, Effect of ACTH4–10 on copulatory and sexually motivated approach behavior in the male rat, in: Sexual Behavior: Pharmacology and Biochemistry (M. Sandler and G. L. Gessa, eds.), Raven Press, New York, pp. 269–275.
Bohus, B., Van Wimersma Greidanus, Tj. B., and De Wied, D., 1975b, Behavioral and endocrine responses of rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain), Physiol. Behav. 14: 609–615.
Bohus, B., Urban, I., van Wimersma Greidanus, Tj. B., and De Wied, D., 1978a, Opposite effects of oxytocin and vasopressin on avoidance behavior and hippocampal theta rhythm in the rat, Neuropharmacology 17: 239–247.
Bohus, B., Kovacs, G. L., and De Wied, D., 1978b, Oxytocin, vasopressin and memory: Opposite effects on consolidation and retrieval processes, Brain Res. 157:414–17.
Bollok, I., Vecsei, L., and Telegdy, G., 1983, The effects of interaction between propranol and somatostatin on the active avoidance behavior, open-field activity and electroconvulsive-shock-induced amnesia of rats, Neuropeptides 3: 263–270.
Bookin, H. B., and Pfeifer, W. D., 1977, Effect of lysine vasopressin on pentylenetetrazol- induced retrogade amnesia in rats, Pharmacol. Biochem. Behav. 7: 51–54.
Branconnier, R. J., Cole, J. O., and Gardos, G., 1979, ACTH4–10 in amelioration of neuropsychological symptomatology associated with senile organic syndrome, Psychopharmacology 61: 161–165.
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., and Guillemin, R., 1973, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science 179: 77–79.
Brito, G. N. O., Thomas, G. J., Gingold, S. I., and Gash, D. M., 1980, Behavioral characteristics of vasopressin-deficient rats (Brattleboro strain), Brain Res. Bull. 6: 71–75.
Brown, M., and Vale, W., 1975, Central nervous system effects of hypothalamic peptides, Endocrinology 96: 1333–1336.
Burbach, J. P. H., Kovacs, G. L., De Wied, D., van Gispen, J. W., and Greven, H. M., 1983, A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide, Science 221: 1310–1312.
Carew, T. J., 1970, Do passive avoidance tasks permit assessment of retrograde amnesia in rats? J. Comp. Physiol. Psychol. 72: 267–271.
Carey, R. J., and Miller, M., 1982, Absence of learning and memory deficits in the vasopressin deficient rat (Brattleboro strain), Behav. Brain Res. 6: 1–13.
Carraway, R., and Leeman, S. E., 1973, The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami, J. Biol. Chem. 248: 6854–6861.
Celestian, J. F., Carey, R. J., and Miller, M., 1975, Unimpaired maintenance of a conditioned avoidance response in the rat with diabetes insipidus, Physiol. Behav. 15:707–711.
Chang, M. M., and Leeman, S. E., 1970, Isolation of a gialogic peptide from bovine hypothalamus and its characterization as substance P, J. Biol. Chem. 245: 4784–4790.
Chard, T., 1972, The posterior pituitary in human and animal parturition, J. Reprod. Fertil. (Suppl 16): 121–138.
Cohen, S. L., Knight, M., Tamminga, C. A., and Chase, T. N., 1982, Cholecystokinin-octapeptide effects on conditioned avoidance behavior, stereotype and catalepsy, Eur. J. Pharmacol. 83: 213–22.
Cohn, M. L., and Cohn, M., 1975, “Barrel rotation” induced by somatostatin in the nonlesioned rat, Brain Res. 96:138–141.
Davies, P., Katzman, R., and Terry, R. D., 1980, Reduced somatostatin-like immunoreactivity in the cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia, Nature 288: 279–280.
de Almeida, M. A., and Izquierdo, M. R., 1984, Effect of intraperitoneal and intracerebroventricular administration of ACTH, epinephrine, or β-endorphin on retrieval of an inhibitory avoidance task in rats, Behav. Neural. Biol. 40: 119–122.
Deutsch, J. A., and Hardy, W. T., 1977, Cholecystokinin produces bait shyness in rats, Nature 266: 196.
De Wied, D., 1964, Influence of anterior pituitary on avoidance learning and escape behavior, Am. J. Physiol. 207: 255–259.
De Wied, D., 1965, The influence of the posterior and intermediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats, Int. J. Neuropharmacol. 4: 157–67.
De Wied, D., 1966, Inhibitory effect of ACTH and related peptides on extinction of conditioned avoidance behavior in rats, Proc. Soc. Exp. Biol. Med. 122: 28–32.
De Wied, D., 1969, Effects of peptide hormones on behavior, in: Frontiers in Neuroendocrinology (W. E. Ganong and L. Martini, eds.), Oxford University Press, New York/London, pp. 97–140.
De Wied, D., 1971, Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats, Nature 232: 58–60.
De Wied, D., 1974, Pituitary-adrenal system hormones and behavior, in: The Neurosciences. Third Study Program (F. G. Schmitt and F. G. Worden, eds.), MIT Press, Cambridge, MA, pp. 653–666.
De Wied, D., 1976, Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments, Life Sci. 19: 685–690.
De Wied, D., 1980, Pituitary-adrenal system hormones and behavior, in: Selye’s Guide to Stress Research, Vol. 1 (H. Selye, ed.), Van Nostrand Reinhold Co., New York, pp. 252–279.
De Wied, D., 1984a, The importance of vasopressin in memory, Trends Neurosci. 7: 62–64.
De Wied, D., 1984b, The importance of vasopressin in memory, Trends Neurosci. 7: 109.
De Wied, D., and Bohus, B., 1979, Modulation of memory processes by neuropeptides of hypothalamic-neurophypophyseal origin, in: Brain Mechanism in Memory and Learning: From the Single Neuron to Man (M. A. B. Brazier, ed.), Raven Press, New York, pp. 139–149.
De Wied, D., and Gispen, W. H., 1977, Behavioral effects of peptides, in: Peptides in Neurobiology (H. Gainer, ed.), Plenum Press, New York, pp. 397–448.
De Wied, D., Bohus, B., and van Wimersma Greidanus, Tj. B., 1975a, Memory deficit in rats with hereditary diabetes insipidus, Brain Res. 85: 152–156.
De Wied, D., Witter, A., and Greven, H. M., 1975b, Behaviourally Active ACTH Analogs, Biochem. Pharmacol. 24: 1463–1468.
De Wied, D., Bohus, B., van Ree, J. M., and Urban, I., 1978a, Behavioral and electrophysiological effects of peptides related to lipotropin (β-LPH), J. Pharmacol. Exp. Ther. 204: 570–580.
De Wied, D., Kovacs, G. L., Bohus, B., Van Ree, J. M., and Greven, H. M., 1978b, Neuroleptic Activity of the neuropeptide β-LPH 62–77, Eur. J. Pharmacol. 49: 427–436.
De Wied, D., van Ree, J. M., and Greven, H. M., 1980, Neuroleptic-like activity of peptides related to [Des-Tyr 1] β-endorphin: Structure activity studies, Life Sci. 26: 1575–1579.
De Wied, D., Gaffori, O., van Ree, J. M., and deJong, W., 1984, Central target for the behavioral effects of vasopressin neuropeptides, Nature 305: 276–278.
Deyo, S. N., Shoemaker, W. J., Ettenberg, A., Bloom, F. E., and Koob, G. F., 1986, Subcutaneous administration of behaviorally effective doses of arginine vasopressin results in brain uptake in only the median eminence, Neuroendocrinology 42: 260–266.
Dobry, P.J. K., Piercey, M. F., and Schroeder, L. A., 1981, Pharmacological characterization of scratching behavior induced by intracranial injection of substance P and somatostatin, Neuropharmacology 20: 267–272.
Emson, P. C., 1979, Peptides as neurotransmitter candidates in the mammalian CNS, Prog. Neurobiol. 13: 61–116.
Ettenberg, A., 1984, Intracerebroventricular application of a pressor antagonist of vasopressin prevents both the “memory” and “aversive” actions of vasopressin, Behav. Brain Res. 14: 201–211.
Ettenberg, A., Le Moal, M., Koob, G. F., and Bloom, F. E., 1983a, Vasopressin potentiation in performance of a learned appetitive task: Reversal by a pressor antagonist analog of vasopressin, Pharmacol. Biochem. Behav. 18: 645–647.
Ettenberg, A., van der Kooy, D., Le Moal, M., Koob, G. F., and Bloom, F. E. 1983b, Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? Behav. Brain Res. 7: 331–350.
von Euler, U. S., and Gaddum, J. H., 1931, An unidentified depressor substance in certain tissue extracts, J. Physiol. London72: 74–87.
Fekete, M., Kadar, T., Penke, B., and Telegdy, G., 1981a, Modulation of passive avoidance behaviour by cholecystokinin octapeptides in rats, Neuropeptides 1: 301–304.
Fekete, M., Lonovics, J., and Telegdy, G., 1981b, Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin antiserum, Neuropeptides 1: 363–369.
Fekete, M., Szabo, A., Balazo, M., and Telegdy, G., 1981c, Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats, Acta Physiol. Acad. Sci. Hung. 58: 39.
Ferris, S. H., Sathanathan, G., Gershon, S., Clark, C., and Moskinsky, J., 1976, Cognitive effects of ACTH4–10 in the elderly, Pharmacol. Biochem. Behav. 5: 73–78.
Fewtrell, W. D., House, A. O., Jamie, P. F., Oates, M. R., and Cooper, J. E., 1982, Effects of vasopressin on memory and new learning in a brain-injured population, Psychol. Med. 12: 423–425.
File, S. E., 1978, ACTH but not corticosterone impairs habituation and reduces exploration, Pharmacol. Biochem. Behav. 9: 161–166.
File, S., 1979, Effects of ACTH4–10 in the social interaction test of anxiety, Brain Res. 171: 157–160.
Frame, C. M., Davidson, M. B., and Sturdevant, R. A. L., 1975, Effects of the octapeptide of cholecystokinin on insulin and glucagon secretion in the dog, Endocrinology 97:549–553.
Frederickson, R. C. A., Burgis, V., Harrell, C. E., and Edwards, J. D., 1978, Dual action of substance P on nociception: Possible role of endogenous opioids, Science 199: 1359–1362.
Gaffori, O., Stewart, J. M., and De Wied, D., 1984, Influence of substance P and fragments on passive avoidance behavior, Experientia 40: 89–91.
Gaillard, A. W. K., 1981, ACTH analogs and human performance, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A. Jensen, R. B. Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 181–196.
Gaillard, A. W. K., and Sanders, A. F., 1975, Some effects of ACTH4–10 on performance during a serial reaction task, Psychopharmacologia 42: 201–208.
Gaillard, A. W. K., and Varey, C. A., 1979, Some effects of an 4–10 analog (ORG 2766) on human performance, Physiol. Behav. 23: 79–84.
Gallagher, M., 1982, Naloxone enhancement of memory processes, effects of other opiate antagonists, Behav. Neural. Biol. 35: 375–382.
Gallagher, M., and Kapp, B. S., 1978, Manipulation of opiate activity in the amygdala alters memory processes, Life Sci. 23: 1973–1978.
Gallagher, M., King, R. A., and Young, N. B., 1983, Opiate antagonists improve spatial memory, Science 221: 975–976.
Garrud, P., Gray, J. A., and De Wied, D., 1974, Pituitary-adrenal hormones and extinction of rewarded behavior in the rat, Physiol. Behav. 12: 109–119.
Gash, D. M., and Thomas, G. J., 1983, What is the importance of vasopressin in memory processes? Trends Neurosci. 6: 197–198.
Gash, D. M., and Thomas, G. J., 1984, Reply from Don M. Gash and Garth J. Thomas, Trends Neurosci. 7: 64–65.
Gibbs, J., Young, R. C., and Smith, G. P., 1973, Cholecystokinin elicits satiety in rats with open gastric fistulas, Nature 245: 323–325.
Gold, P. E., and McGaugh, J. L., 1977, Hormones and memory, in: Neuropeptide Influences on the Brain and Behavior (L. H. Miller, C. A. Sandman, and A. J. Kastin, eds.), Raven Press, New York, pp. 127–143.
Gold, P. E., and van Buskirk, R. B., 1976, Enhancement and impairment of memory processes with posttrial injections of adrenocorticotropic hormone, Behav. Biol. 16:387–400.
Gray, J. A., 1971, Effect of ACTH on extinction of rewarded behaviour is blocked by previous administration of ACTH, Nature 119: 52–54.
Gray, J. A., and Garrud, P., 1977, Adrenopituitary hormones and frustrative nonreward, in: Neuropeptides Influences on the Brain and Behavior. Advances in Biochemical Psychopharmacology, Vol. 17 (L. H. Miller, C. A. Sandman, and A.J. Kastin, eds.), Raven Press, New York, pp. 201–212.
Greven, H. M., and De Wied, D., 1973, The influence of peptides derived from corticotrophin (ACTH) on performance. Structure-activity studies, in: Drug Effects on Neuroendocrine Regulation, Progress in Brain Research, Vol. 39 (E. Zimmerman, W. H. Gispen, B. H. Marks, and D. De Wied, eds.), Elsevier, Amsterdam, pp. 429–442.
Guth, S., Levine, S., and Seward, J. P., 1971, Appetitive acquisition and extinction effects with exogenous ACTH, Physiol Behav. 7: 195–200.
Hall, M. E., and Stewart, J. M., 1982, Opposite behavioral effects of N- and C-terminal fragments of substance P, Soc. Neurosci. Abstr. 8: 369.
Hays, R. M., 1980, Agents affecting the renal conservation of water, in: The Pharmacological Basis of Therapeutics, 6th ed. (A. G. Gilman, L. S. Goodman, and A. Gilman, eds.), Macmillan, New York, pp. 916–934.
Hecht, K., Oehme, P., and Poppel, M., 1982, Action of substance P and SP-hexapeptide analogue on avoidance learning in rats, Pharmazie 37: 791–792.
Heise, G. A., 1981, Learning and memory facilitators: Experimental definition and current status, Trends Pharmacol Sci. 2: 158–160.
Hennessy, J. W., Cohen, M. E., and Rosen, A. J., 1973, Adrenocortical influences upon the extinction of an appetitive runway response, Physiol Behav. 11: 767–770.
Hokfelt, T., Rehfeld, J. F., Skirboll, L., Ivemark, B., Goldstein, M., and Markey, K., 1980, Evidence for coexistence of dopamine and CCK in mesolimbic neurones, Nature 285: 476–478.
Hostetter, G., Jubb, S. L. and Kozlowski, G. P., 1977, Vasopressin affects the behavior of rats in a positively-rewarded discrimination task, Life Sci. 21: 1323–1328.
Hunter, B., Zornetzer, S. F., Jarvik, M. E., and McGaugh, J. L., 1977, Modulation of learning and memory: Effects of drugs influencing neurotransmitters, in: Handbook of Psychopharmacology, Vol. 18 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 531–577.
Huston, J. P., and Staubli, U., 1978, Retrograde amnesia produced by post-trial injection of substance P into substantia nigra, Brain Res. 159: 468–472.
Huston, J. P., and Staubli, U., 1979, Post-trial injection of substance P into lateral hypothalamus and amygdala, respectively facilitates and impairs learning, Behav. Neural Biol 27: 244–248.
Iversen, S. A., 1981, Neuropeptides: Do they integrate body and brain? Nature 291: 454.
Izquierdo, I., 1979, Effect of naloxone and morphine on various forms of memory in the rat: Possible role of endogenous opiate mechanisms in memory consolidation, Psychopharmacology 66: 199–203.
Izquierdo, I., 1980a, Effect of beta-endorphin and naloxone on acquisition, memory and retrieval of shuttle avoidance and habituation learning in rats, Psychopharmacology 69: 111–115.
Izquierdo, I., 1980b, Effect of a low and high dose of Beta-endorphin on acquisition and retention in the rat, Behav. Neural Biol 30: 460–464.
Izquierdo, I., and Dias, R. D., 1981, Retrograde amnesia caused by Met-Leu- and Des Tyr- Met enkephalin in the rat and its reversal by naloxone, Neurosci. Lett. 22: 189–193
Izquierdo, I., Souza, D. O., Carrasco, M. A., Dias, R. D., Perry, M. L., Eisinger, S., Elisabetsky, E., and Vendite, D. A., 1980a, Beta-endorphin causes retrograde amnesia and is released from the rat brain by various forms of training and stimulation, Psychopharmacology 39: 460–464.
Izquierdo, I., Dias, R. D., Souza, D. O., Carrasco, M. A., Elisabetsky, E., and Perry, M. L., 1980b, The role of opioid peptides in memory and learning, Behav. Brain Res. 1:451–468.
Izquierdo, I., Dias, R. D., Souza, D. O., Carrasco, M. A., Elisabetsky, and Perry, M. L., 1980c, The role of opioid peptides in memory and learning, Behav. Brain Res. 1: 451–468.
Izquierdo, I., Paiva, A. C. M., and Elisabetsky, E., 1980c, Post-training intraperitoneal administration of leu-enkaphalin and beta-endorphin causes retrograde amnesia for two different tasks in rats, Behav. Neural Biol 28: 246–250.
James, W. J., 1961, Psychology: The Briefer Course (G. Allport, ed.), Harper and Brothers, New York, pp. 240–257.
Jenkins, J. S., Mather, H. M., Caughlan, A. K., and Jenkins, D. G., 1979, Desmopressin in posttraumatic amnesia, Lancet 2: 1245–1246.
Jenkins, J. S., Mather, H. M., Caughlan, A. K., and Jenkins, D. G., 1981, Desmopressin and desglycinamide vasopressin in post traumatic amnesia, Lancet 1: 39.
Kadar, T., Fekete, M., and Telegdy, G., 1981, Modulation of passive avoidance behaviors of rats by intracerebroventricular administration of cholecystokinin in octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide, Acta Physiol. Acad. Sci. Hung. 58: 269–274.
Kastin, A., Miller, L., Nockton, R., Sandman, C. Schally, A., and Stratton,, L., 1973, Behavioral aspects of melanocyte stimulating hormone (MSH), in: Drug Effect on Neuroendocrine Regulation, Progress in Brain Research (E. Zimmerman, W. Gispen, B. Marks, and D. De Wied, eds.), Elsevier Scientific Pub. Co., Amsterdam, pp. 461–470.
Katz, R. J., 1979, Central injection of substance P elicits grooming behavior and motor inhibition in mice, Neurosci. Lett. 12: 133–136.
Kelley, A. E., and Iversen, S. D., 1979, Behavioral activation induced in the rat by substance P infusion into ventral tegmental area: Implication of dopaminergic AIO neurons, Neurosci. Lett. 11: 335–339.
Kobayashi, R. M., Brown, M. R., and Vale, W., 1977, Regional distribution of neurotensin and somatostatin in rat brain, Brain Res. 126: 584–588.
Koch-Hendriksen, N., and Nielsen, H., 1981, Vasopressin in posttraumatic amnesia, Lancet 2: 38–39.
Koller, M., Krause, H. P., Hoffmeister, F., and Garten, D., 1979, Endogenous brain angiostensin II disrupts passive avoidance behavior in rates, Neurosci. Lett. 14: 71–75.
Koob, G. F., and Bloom, F. E., 1983, Behavioural effects of opioid peptides, Br. Med. Bull. 39: 89–94.
Koob, G. F., Le Moal, M., and Bloom, F. E., 1981a, Enkephalin and endorphin influences on appetitive and aversive conditioning, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A. Jensen, R. B. Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 305–324.
Koob, G. F., Le Moal, M., Gaffori, O., Manning, M., Sawyer, W. H., Rivier, J., and Bloom, F. E., 1981b, Arginine vasopressin and a vasopressin antagonist peptide: Opposite effects on extinction of active avoidance in rats, Reg. Peptide 2:153–163.
Koob, G. F., Dantzer, R., Bluthé, R.-M., Lebrun, C., Bloom, F. E., and Le Moal, M., 1986, Central injections of arginine vasopressin prolong extinction of active avoidance, Peptides 7: 213–218.
Koob, G. F., LeBrun, C., Martinez, J. L., Jr., Dantzer, R., Le Moal, M., and Bloom, F. E., 1985, Arginine vasopressin, stress and memory, in: Vasopressin (R. Schrier, ed.), Raven Press, New York, pp. 195–201.
Kovacs, G. L., Vescei, L., and Telegdy, G., 1978, Opposite action of oxytocin to vasopressin in passive avoidance in rates, Physiol. Behav. 20: 801–802.
Kovacs, G. L., Bohus, B., and Versteeg, D. H. G., 1979a, Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal noradrenergic bundle? Brain Res. 172: 73–85.
Kovacs, G. L., Bohus, B., Versteeg, D. H. G., De Kloet, E. R., and De Wied, D., 1979b, Effect of oxytocin and vasopressin on memory consolidation sites of action and catecholaminergic correlates after micro injection into limbic-midbrain structures, Brain Res. 175: 303–314.
Kovacs, G. L., Bohus, B., and De Wied, D., 1981a, Retention of passive avoidance behavior in rats following alpha and gamma endorphin administration: Effects of postlearning treatments, Neurosci. Lett. 22: 79–82.
Kovacs, G. L., and De Wied, D., 1981b, Endorphin influences on learning and memory, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A. Jensen, R. B. Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 231–247.
Kreiger, D. J., Liotta, A., and Brownstein, M. J., 1977, Presence of corticotropin in limbic system of normal and hypophysectomized rats, Brain Res. 128: 575–579.
Kulback, S., 1968, Information Theory and Statistics, Dover, New York.
Laczi, F., van Ree, J. M., Wagner, A., Valkusz, Z., Jardanhazy, T., Kovacs, G. L., Telegdy, G., Szilard, J., Laszlo, F. A., and De Wied, D., 1983, Effects of desglycinamide- arginine vasopressin (DG-AVP) on memory processes in diabetes insipidus patients and non diabetic subjects, Acta Endocrinol. 102: 205–212.
Lande, S., Flexner, T. B., and Flexner, L. L., 1972, Effects of corticotrophin and desglycinamide lysine vasopressin on suppression of memory by puromycin, Proc. Natl. Acad. Sci. USA 69: 558–60.
LeBoeuf, A., Lodge, J., and Eames, P. G., 1978, Vasopressin and memory in Korsakoff syndrome, Lancet 2: 1370.
Lebrun, C. J., Rigter, H., Martinez, J. L., Jr., Koob, G. F., Le Moal, M., and Bloom, F. E., 1984, Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPTyr (Me) AVP], Life Sci. 35: 1505–1512.
Lebrun, C., Le Moal, M. Koob, G. F., and Bloom, F. E., 1985, Vasopressin pressor antagonist injected centrally reverses peripheral behavioral effects of vasopressin but only at doses that reverse increases in blood pressure, Reg. Peptides 11: 173–181.
Legros, J. J., Gilot, P., Seron, X., Claessens, J., Adam, A., Moeglen, J. M., Audibert, A., and Berchier, P., 1978, Influence of vasopressin on learning and memory, Lancet 1: 41–42.
Le Moal, M., Koob, G. F., and Bloom, F. E., 1979, Endorphins and extinction differential actions on appetitive and aversive tasks, Life Sci. 24: 1631–1636.
Le Moal, M., Koob, G. F., Koda, L. Y., Bloom, F. E., Manning, M., Sawyer, W. H., and Rivier, J., 1981, Vasopressin antagonist peptide: Blockade of pressor receptor prevents behavioral action of vasopressin, Nature 291: 491–493.
Le Moal, M., Koob, G. F., Mormede, P., Dantzer, R., and Bloom, F. E., 1982, Vasopressin pressor antagonist reverses central behavioral effects of vasopressin, Neurosci. Abstr. 8: 368.
Le Moal, M., Dantzer, R., Mormede, P., Baduel, A., Lebrun, C., Ettenberg, A., van der Kooy, D., Wenger, J., Deyo, S., Koob, G. F., and Bloom, F. E., 1984, Behavioral effects of peripheral administration of arginine vasopressin: A review of our search for a mode of action and a hypothesis, Psychoneuroendocrinology 9: 319–341.
Levine, S., and Jones, L. E., 1965, Adrenocorticotrophic hormone (ACTH) and passive avoidance learning, J. Comp. Physiol. Psychol. 59: 357–360.
Levine, S., Smotherman, W. P., and Hennessy, J. W., 1977, Pituitary-adrenal hormones and learned taste aversion, in: Neuropeptide Influences on the Brain and Behavior (L. H. Miller, C. A. Sandman, and A. J. Kastin, eds.), Raven Press, New York, pp. 163–177.
Lissak, K., and Bohus, B., 1972, Pituitary hormones and avoidance behavior of the rat, Int. J. Psychobiol. 2: 103–115.
Lucion, A. B., Rosito, G., Sapper, D., Palmini, A. L., and Izquierdo, I., 1982, Intracerebroventricular administration of nanogram amounts of α-endorphin and methionine enkephalin causes retrograde amnesia in rats, Behav. Brain Res. 4: 111–115.
Luttinger, D., Nemeroff, C. B., and Prange, A. J., Jr., 1982, The effects of neuropeptides on discrete-trial conditioned avoidance responding, Brain Res. 237: 183–192.
Martinez, J. L., Jr., 1985, Endogenous modulators of learning and memory to be published, in: Theory in Psychopharmacology, Vol. 2 (S. Cooper, ed.), Academic Press, London.
Martinez, J. L., Jr., and Rigter, H., 1980, Endorphins alter acquisition and consolidation of an inhibitory avoidance response in rats, Neurosci. Lett. 19: 197–201.
Martinez, J. L., Jr., and Rigter, H., 1982, Enkephalin actions on avoidance conditioning may be related to adrenal medullary function, Behav. Brain Res. 6: 289–299.
Martinez, J. L. Jr., Rigter, H., Jensen, R. A., Messing, R. B., Vasquez, B. J., and McGaugh, J. L., 1981, Endorphin and enkephalin effects on avoidance conditioning, the other side of the pituitary-adrenal axis, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A.Jensen, R. B. Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 395–324.
Martinez, J. L., Jr., Conner, P., Dana, R. C., Chavkin, C., Bloom, F., and de Graff, J., 1984a, Endogenous modulation of peripheral leu-enkephalin systems affects avoidance conditioning, Neurosci. Abstr. 10: 176.
Martinez, J. L., Jr., Olson, K., and Hilston, C., 1984b, Opposite effects of met-enkephalin and leu-enkephalin on a discriminated shock-escape task, Behav. Neurosci. 98:487–495.
Martinez, J. L., Jr., Conner, P., and Dana, R. C., 1985, Central versus peripheral actions of leu-enkephalin on acquisition of a one-way active avoidance response in rats, Brain Res. 327: 37–43.
McGaugh, J. L., 1966, Time-dependent processes in memory storage, Science 153:1351–1358.
McGaugh, J. L., 1973, Drug facilitation of learning and memory, Annu. Rev. Pharmacol. 13: 1351–1358.
McGaugh, J. L., 1983, Preserving the presence of the past: Hormonal influences on memory storage, Am. Psychologist 38: 161–174.
McGaugh, J. L., and Martinez, J. L., Jr., 1981, Learning modulatory hormones: An introduction to endogenous peptides and learning and memory processes, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A.Jensen, R. B. Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 1–3.
Mens, W. B., Wiher, A., and van Wimersma Greidanus, Tj. B., 1983, Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): Half-times of disappearance of these neuropeptides from CSF, Brain Res. 262: 143–149.
Messing, R. B., and Sparber, S. R., 1983, Des-Gly-vasopressin improves acquisition and slows extinction of autoshaped behavior, Eur. J. Pharmacol. 89: 43–51.
Messing, R. B., Jensen, R. A., Martinez, J. L. Jr., Spiehler, V. R., Vasquez, B. J., Soumireu-Mourat, B., Liang, D. C., and McGaugh, J. L., 1979, Naloxone Enhancement Of Memory, Behav. Neural. Biol. 27: 266–275.
Messing, R. B., Jensen, R., Vasquez, B. J., Martinez, J. L., Spiehler, V. R., and McGaugh, J. L., 1981, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A.Jensen, R. B., Messing, H. Rigter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 431–444.
Miller, R. E., and Ogawa, N., 1962, The effect of adrenocorticotrophic hormone (ACTH) on avoidance conditioning in the adrenalectomized rat, J. Comp. Physiol. Psychol. 55: 211–213.
Miller, R. E., and Caul, W. F., 1973, Effect of adrenocorticotropic hormone on appetitive discrimination learning in the rat, Physiol. Behav. 10: 141–143.
Miller, L. H., Harris, L. C., van Riezen, H., and Kastin, A. J., 1976, Neuroheptapeptide influence on attention and memory in man, Pharmacol. Biochem. Behav. 5 (Suppl. 1):17–21.
Miller, L. H., Kastin, A. J., Sandman, C. A., Fink, M., and Van Veen, W. J., 1974, Polypeptide influences on attention, memory, and anxiety in man, Pharmacol. Biochem. Behav. 2: 663–668.
Morgan, J. M., and Routtenberg, A., 1977, Angiotensin injected into the neostriatum after learning disrupts retention performance, Science 196: 87–89.
Murphy, J. V., and Miller, R. E., 1955, The effect of adrenocorticotrophic hormone (ACTH) on avoidance conditioning in the rat, J. Comp. Physiol. Psychol. 48: 47–49.
Nemeroff, C. B., 1980, Neurotensin: Perhaps an endogenous neuroleptic? Biol. Psychiatry 15: 283–302.
Nemeroff, C. B., Luttinger, D. and Prange, A. J., Jr., 1983, Neurotensin and bombesin, in: Handbook of Psychopharmacology, Vol. 16 (L. H. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 363–466.
Olendorf, W. H., 1974, Blood-brain barrier permeability to drugs, Annu. Rev. Pharmacol. 14: 239–248.
Oliveros, J. C., Jandali, M. K., Timsit-Berthier, M., Remy, R., Benghezal, A., Audibert, A., and Moeglen, J. H., 1978, Vasopressin in amnesia, Lancet 1: 42.
Pardridge, W. M., 1983, Neuropeptides and the blood-brain barrier, Annu. Rev. Physiol. 45: 73–82.
Pederson, C. A., and Prange, A. J., 1979, Induction of maternal behaviour in virgin rats after intracerebroventricular administration of oxytocin, Proc. Natl. Acad. Sci. USA 76: 661–665.
Prange, A. J., Jr., Nemeroff, C. B., Lipton, M. A., Breese, G. R., and Wilson, I. C., 1978, Peptides and the central nervous system, in: Handbook of Psychopharmacology (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 1–106.
Rezek, M., Havlicek, V., Hughes, K. R., and Friesen, H., 1977, Behavioural and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into amygdala, Neuropharmacology 16: 157–162.
Rigter, H., 1978, Attenuation of amnesia in rats by systemically administered enkephalin, Science 200: 83–85.
Rigter, H., 1982, Vasopressin and memory: The influence of prior experience with the training situation, Behav. Neural. Biol. 34: 337–351.
Rigter, H., and Popping, A., 1976, Hormonal influences on the extinction of conditioned taste aversion, Psychopharmacologia (Berlin) 46: 255–261.
Rigter, H., and van Riezen, H., 1975, Anti-amnesic effect of ACTH4–10: Its independence of the nature of the amnesic agent and the behavioral test, Physiol. Behav. 14: 563–566.
Rigter, H., and van Riezen, H., 1978, Hormones and Memory, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. Di Masco, and K. F. Killam, eds.), Raven Press, New York, pp. 677–689.
Rigter, H., van Riezen, H., and De Wied, D., 1974, The effects of ACTH and vasopressin- analogues on CO2-induced retrograde amnesia in rats, Physiol. Behav. 13: 381–388.
Rigter, H., Janssens-Elbertse, R., and van Riezen, H., 1976, Reversal of amnesia by an orally active ACTH4_9 analog (Org 2766), Pharmacol. Biochem. Behav. 5 (Suppl. 1): 53–58.
Rigter, H., Shuster, S., and Thody, A. J., 1977, ACTH αMSH and β-LPH: Pituitary hormone with similar activity in an amnesia test in rats, J. Pharm. Pharmacol. 29: 110–111.
Rigter, H., Hannan, T. J., Messing, R. B., Martinez, J. L., Jr., Vasquez, B. J., Jensen, R. A., Veliquette, J., and McGaugh, J. L., 1980a, Enkephalins interfere with acquisition of an active avoidance response, Life Sci. 26: 337–345.
Rigter, H. Jensen, R. A., Martinez, J. L., Jr., Messing, R. B., Vasquez, B. J., Liang, K. C., and McGaugh, J. L., 1980b, Enkephalin and Fear-Motivated Behavior, Proc. Natl. Acad. Sci. USA 77: 3729–3732.
Rigter, H., Dekker, I., and Martinez, J. L., Jr., 1981, A comparison of the ability of opioid peptides and opiates to affect active avoidance conditioning in rats, Reg. Peptides 2: 317–322.
Rossor, M. N., Emson, P. C., Mountjoy, C. Q., Roth, M., and Iversen, L. L., 1980, Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type, Neurosci. Lett. 20: 373–377.
Roth, M. M., Heath, R. G., and Ward, M., 1975, Angiotensin-converting enzyme in human brain, J. Neurochem. 25: 83–85.
Sahgal, A., 1984, A critique of the vasopressin memory hypothesis, Psychopharmacology 83: 215–228.
Sahgal, A., and Wright, C., 1983, A comparison of the effects of vasopressin and oxytocin with amphetamine and chlordiazepoxide on passive avoidance behaviour in rats, Psychopharmacology 80: 88–92.
Sahgal, A., Keith, A. B., Wright, C., and Edwardson, J. A., 1982, Failure of vasopressin to enhance memory in a passive avoidance task in rats, Neurosci. Lett. 28: 87–92.
Sandman, C. A., Miller, L. H., Kastin, A. J., and Schally, A. V., 1972, A neuroendocrine influence on attention and memory, J. Comp. Physiol. Psychol. 80: 54–58.
Sandman, C. A., Alexander, W. D., and Kastin, A. J., 1973a, Neuroendocrine influences on visual discrimination and reversal learning in the albino and hooded rat, Physiol. Behav. 11: 613–617.
Sandman, C., Kastin, A., and Schally, A., 1973b, Melanocyte-stimulating hormone and learned appetitive behavior, Experientia 92: 372–379.
Sandman, C. A., Beckwith, B. E., Giddis, M. M., and Kastin, A. J., 1974, Melanocyte stimulating hormone (MSH) and overtraining effects on extradimensional shift (EDS) learning, Physiol. Behav. 13: 163–166.
Sandman, C. A., George, J. M., Nolan, J., Van Riezen, H., and Kastin, A. J., 1975, Enhancement Of Attention In Man With Acth/Msh4–10, Physiol. Behav. 15: 427–431.
Sandman, C. A., George, J., Walker, B. B., and Nolan, J. D., 1976, Neuropeptide MSH- ACTH4–10 enhances attention in the mentally retarded, Pharmacol. Biochem. Behav. 5 (Suppl. 1): 23–28.
Sandman, C. A., eorge, J., McCanne, T. R., Nolan, J. D., Kaswan, J., and Kastin, A. J., 1977, MSH/ACTH4–10 influences behavioral and physiological measures of attention, J. Clin. Endocrinol. Metab. 44: 884–890.
Sandman, C. A., Beckwith, B. G., and Kastin, A. J., 1980, Are learning and attention related to the sequence of amino acids in ACTH/MSH peptides? Peptides 1: 277–280.
Sandman, C. A., Kastin, A. J., and Schally, A. V., 1981, Neuropeptide influences on the central nervous system, A psychobiological perspective, in: Neuroendocrine Regulation and Altered Behaviour (P. D. Hrdina and R. L. Singhal, eds.), Croom Helm Ltd., London, pp. 3–28.
Sawyer, W. H., 1964, Vertebrate neurophypophysial principles, Endocrinology 75: 981–990.
Schlesinger, K., Lipsitz, D. U., Peck, P. L., Pelleymounter, M. A., Stewart, J. M., and Chase, T. N., 1983a, Substance P enhancement of passive and active avoidance conditioning in mice, Pharmacol. Biochem. Behav. 19: 655–661.
Schlesinger, K., Lipsitz, D. U., Peck, P. L., Stewart, J. M., and Chase, T. N., 1983b, Substance P reversal of electroconvulsive shock and cycloheximide-induced retrograde amnesia, Behav. Neural. Biol. 39:30–39.
Schneider, L. H., Alpert, J. E., and Iversen, S. D., 1983, CCK 8 modulation of mesolimbic dopamine: Antagonism of amphetamine stimulated behaviors, Peptides 4: 749–753.
Schulz, H., Kovacs, G. L., and Telegdy, G., 1974, Effects of doses of vasopressin and oxytocin on avoidance behavior in rats, Acta Physiol. Acad. Sci. Hun. 45: 211–215.
Schulz, H., Kovacs, G. L., and Telegdy, G., 1976, The effect of vasopressin and oxytocin on avoidance behavior in rats, in: Cellular and Molecular Bases of Neuroendocrine Processes (E. Endroczi, ed.), Akademia, Kindo, Budapest, pp. 555–564.
Squire, L. R., and Davis, H. P., 1981, The pharmacology of memory: A neurobiological perspective, Annu. Rev. Pharmacol. Toxicol. 21: 323–356.
Starr, M. S., James, T. A., and Gaytten, D., 1978, Behavioral depressant and antinociceptive properties of substance P in the mouse: Possible implication of brain monamines, Eur. J. Pharmacol. 48: 203–212.
Staubli, U., and Huston, J. P., 1979, Differential effects on learning by ventromedial vs. lateral hypothalamic injection of substance P, Pharmacol. Biochem. Behav. 10: 783–786.
Staubli, U., and Huston, J. P., 1980, Facilitation of learning by post-trial injection of substance P into the medial septal nucleus, Behav. Brain Res. 1: 245–255.
Stewart, J. M., Getto, C. J., Nelder, K., Reeve, E. B., Krivoy, W. A., and Zimmerman, E., 1976, Substance P and Analgesia, Nature 262: 784–785.
Stinus, L., Kelley, A. E., and Iversen, S. D., 1978, Increased spontaneous activity following substance P infusion into A10 dopaminergic area, Nature 276: 616–618.
Tanaka, M., de Kloet, E. R., De Wied, D., and Versteeg, D. H. G., 1977a, Arginine8- vasopressin affects catecholamine metabolism in specific brain nuclei, Life Sci. 20: 1799–1808.
Tanaka, M., Versteeg, D. H. G., and De, Wied, D., 1977b, Regional effects of vasopressin on rat brain catecholamine metabolism, Neurosci. Lett. 4:321–325.
Tazi, A., Dantzer, R., Mormede, P., and Le Moal, M., 1983, Effects of posttrial administration of naloxone and β-endorphin on shock induced fighting in rats, Behav. Neural. Biol. 39: 192–202.
Tazi, A., Dantzer, R., Normede, P., and Le Moal, M., 1985, Effects of naloxone, β-endorphin and ACTH on acquisition of schedule-induced polydipsia, Psychopharmacology 85: 87–91.
Tinklenberg, J. R., Pfefferbaum, A., and Berger, P. A., 1981, 1-Desamino-D-arginine vasopressin (DDAVP) in cognitively impaired patients, Psychopharmacol. Bull. 17:206–207.
Vaccarino, F. J., and Koob, G. F., 1984, Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward, Neurosci. Lett. 52: 61–66.
Vale, W., Brazeau, P., Rivier, C., Brown, M., Ross, B., River, J., Burgus, R., Ling, N., and Guillemin, R., 1975, Somatostatin Recent Progress, Hormone Res. 31: 365–397.
Vecsei, L., Schwarzberg, H., and Telegdy, G., 1982, The effect of somatostatin on the self-stimulation of rats, Neuroendocrinol. Lett. 4: 37–41.
Vecsei, L., Bollok, I., and Telegdy, G., 1983a, Intracerebroventricular somatostatin attenuates electroconvulsive-shock-induced amnesia in rats, Peptides 4: 293–295.
Vecsei, L., Bollok, I., and Telegdy, G., 1983b, The effect of linear somatostatin on the active avoidance behaviour and open-field activity on haloperidol, phenoxybenzamine, and atropine pretreated rats, Acta Physiol. Hung. 62: 205–211.
Vecsei, L., Bollok, I., and Telegdy, G., 1984, Phenoxybenzamine antagonizes somato- statin-induced anti-amnesia in rats, Eur. J. Pharmacol. 99: 325–328.
van Ree, J. M., Bohus, B., Versteeg, D. H., and De Wied, D., 1978, Neurohypophyseal Principles and Memory Processes, Biochem. Pharmacol. 27: 1793–1800.
van Wimersma Greidanus, Tj. B., and De Wied, D., 1971, Effects of systemic and intracerebral administration of two opposite acting ACTH-related peptides on extinction of conditioned avoidance behaviour, Neuroendocrinology7: 291–301.
van Wimersma Greidanus, Tj. B., Dogterom, J., and De Wied, D., 1975, Intraventricular administration of antivasopressin serum inhibits memory consolidation in rats, Life Sci. 16: 637–644.
van Wimersma Greidanus, Tj. B., and De Wied, D., 1976a, Dorsal hippocampus: A site of action of neuropeptides on avoidance behavior? Pharmacol. Biochem. Behav. 5 (Suppl. l): 29–33.
van Wimersma Greidanus, Tj. B., and De Wied, D., 1976b, Modulation of passive avoidance behavior of rats by intracerebroventricular administration of antivasopressin serum, Behav. Biol. 18:325–333.
van Wimersma Greidanus, Tj. B., Croiset, G., Bakker, I., and Bouman, H., 1979, Amygdaloid lesions block the effect of neuropeptides (vasopressin, ACTH4–10) on avoidance behavior, Physiol. Behav. 22: 291–295.
van Wimersma Greidanus, Tj. B., van Praag, M. C., Kalmann, R., Rinkel, G. J., Croiset, G., Hoeke, E. C., van Egmond, M. A., and Fekete, M., 1982, Behavioral Effects Of Neurotensin, Ann. Ny Acad. Sci. 400: 319–29.
van Wimersma Greidanus, Tj. B., Bohus, B., and De Wied, D., 1983, Vasopressin and oxytocin in learning and memory, in: Endogenous Peptides and Learning and Memory Processes (J. L. Martinez, Jr., R. A.Jensen, R. B. Messing, H. Righter, and J. L. McGaugh, eds.), Academic Press, New York, pp. 413–427.
Verhoef, J., and Witter, A., 1976, In vivo fate of a behaviorally active ACTH4–9 analog in rats after systemic administration, Pharmacol Biochem. Behav. 4: 583–590.
Walker, B. B., and Sandman, C. A., 1979, Influences of an analog of the neuropeptide ACTH4–9 on mentally retarded adults, Am. J. Ment. Defic. 83: 346–352.
Walter, R., van Ree, J. M., and De Wied, D., 1978, Modification of conditioned behavior of rats by neurohypophyseal hormones and analogs, Proc. Natl Acad. Sci. USA 75: 2493–2496.
Weingartner, H., Gold, P., Ballenger, J. C., Smallberg, S. A., Summers, R., Rubinow, D. R., Post, R. M., and Goodwin, F. K., 1981, Effects of vasopressin on human memory functions, Science 211: 601–603.
Weiss, J. M., McEwen, B. S., Silva, M. T. A., and Kalkut, M. F., 1969, Pituitary-adrenal influences on fear responding, Science 163: 197–199.
Weissman, A., 1967, Drugs and memory and learning, Annu. Rep. Med. Chem. 3: 279–289.
Wetzel, W., and Matthies, H., 1982, Effect of substance P on the retention of a brightness discrimination task in rats, Acta Biol Med. Germ. 41: 647–652.
Wood, J. H., 1982, Neuroendocrinology of cerebrospinal fluid: Peptides, steroids and other hormones, Neurosurgery 11: 293–305.
Zaidi, S. M. A., and Heller, H., 1974, Can neurohypophysial hormones cross the blood- cerebrospinal fluid barrier? J. Endocrinol. 60: 195–196.
Zerbe, R. L., Bayorh, M. A., and Feuerstein, G., 1982, Vasopressin: An essential pressor factor for blood pressure recovery following hemorrhage, Peptides 3: 509–514.
Zetler, G., 1981, Central depressant effects of caerulein and cholecystokinin octapeptide (CCK 8) differ from those of diazepam and haloperidol, Neuropharmacology 20: 277–283.
Zornetzer, S. F., 1978, Neurotransmitter modulation and memory: A new neuropharmacological phrenology, in: Psychopharmacology: A Generation of Progress (M. A. Lipton, A. Di Mascio, and K. F. Killan, eds.), Raven Press, New York, pp. 637–649.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Koob, G.F. (1987). Neuropeptides and Memory. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Handbook of Psychopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1819-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1819-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9017-9
Online ISBN: 978-1-4613-1819-4
eBook Packages: Springer Book Archive